Join to View Full Profile
4000 Spencer HwyPasadena, TX 77504
Phone+1 713-359-2000
Fax+1 713-359-1004
Dr. Fairchild is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Medical Branch HospitalsInternship, Transitional Year, 1984 - 1985
The University of Texas Health Science Center at San AntonioClass of 1984
Certifications & Licensure
TX State Medical License 1987 - 2026
American Board of Anesthesiology Anesthesiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Kareo EHR, Kareo, Inc., 2015
- CMS Meaningful Use Stage 1 Certification Shareable Ink, Shareable Ink, 2015
Publications & Presentations
PubMed
- Linking donor-specific antibody generation with natural killer cells in antibody-mediated kidney graft rejection.Griffith B Perkins, Robert L Fairchild
Kidney International. 2023-10-01 - 12 citationsMolecular Signature of Antibody-Mediated Chronic Vasculopathy in Heart Allografts in a Novel Mouse Model.Hidetoshi Tsuda, Nina Dvorina, Karen S Keslar, Jessica Nevarez-Mejia, Nicole M Valenzuela
The American Journal of Pathology. 2022-07-01 - 31 citationsThe neonatal Fc receptor: Key to homeostasic control of IgG and IgG-related biopharmaceuticalsWilliam M. Baldwin, Anna Valujskikh, Robert L. Fairchild
American Journal of Transplantation. 2019-04-15
Journal Articles
- Peri‐Transplant VLA‐4 Blockade Inhibits Endogenous Memory CD8 T Cell Infiltration into High Risk Cardiac Allografts and CTLA‐4Ig Resistant RejectionCharles A Su, Robert L Fairchild, American journal of transplantation
Grant Support
- The role of HLA and its coreceptors in endothelial cell activation and leukocyte recruitment in antibody-mediated transplant rejectionUNIVERSITY OF CALIFORNIA LOS ANGELES2018–2029
- Post-Transplant Inflammatory ResponseCLEVELAND CLINIC LERNER COM-CWRU1997–2029
- Targeting the transcriptional co-activators YAP and TAZ with statins to prevent solid organ transplant rejection by HLA donor specific antibodiesUNIVERSITY OF CALIFORNIA LOS ANGELES2023–2028
- Chronic Antibody-Mediated Rejection of Kidney AllograftsCLEVELAND CLINIC LERNER COM-CWRU2022–2027
- Post-transcriptional regulation of gene expression by microRNAs in antibody-mediated rejectionTUFTS UNIVERSITY BOSTON2022–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
